Elixirgen Scientific is a Maryland - based company specializing in a proprietary transcription factor-based differentiation technology for iPSCs. We are engaged in creating strategic partnerships focused on new cell type development for cell therapy and regenerative medicine, and the optimization of your cell manufacturing process. Our goal is to create clinically relevant and functional cells for drug screening and translational research including the creation of disease panel assays.